Skip to main content
. 2011 Nov 9;2011(11):CD002855. doi: 10.1002/14651858.CD002855.pub4

Creinin 2001 MI600 M400.

Methods random number tables, sealed opaque envelopes
Participants 86 pregnant women, =/> 18 years, ≤ 49 days pregnant, single pregnancy, at the University hospital Pittsburgh, USA 
 exclusion criteria: contraindication to mifepristone/misoprostol administration, haemoglobin < 10 gm/dL, cardiovascular disease, coagulopathies, IUCD in situ, breastfeeding
Interventions mifepristone 600mg (all) 
 group 1: misoprostol 400mcg after 6‐8 hours/oral 
 group 2: misoprostol 400mcg after 48 hours/oral
Outcomes complete abortion, onset and duration of bleeding, side effects
Notes no blinding 
 no major complications were reported
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate